Song, Y
Li, S
Ray, A
Das, D S
Qi, J
Samur, M K
Tai, Y-T
Munshi, N
Carrasco, R D
Chauhan, D
Anderson, K C
Article History
Received: 19 December 2016
Revised: 3 April 2017
Accepted: 1 May 2017
First Online: 5 June 2017
Competing interests
: KCA is on advisory board of Celgene, Millenium, Gilead and Bristol Myers Squibb, and is a Scientific Founder of Acetylon, Oncopep and C4 Therapeutics. The other authors declare no conflict of interest.